1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Peptide Therapeutics Market
3.2. Opportunities in the Peptide Therapeutics Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Peptide Therapeutics Market, by Drug Class
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Calcitonins
5.4. Glucagon & Analogs
5.5. Insulins
5.6. Luteinizing Hormone-Releasing Hormone
5.7. Somatostatins
5.8. Vasopressin
6. Global Peptide Therapeutics Market, by Route of Administrator
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Oral
6.4. Parental
7. Global Peptide Therapeutics Market, by Technology
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hybrid Phase
7.4. Liquid Phase
7.5. Solid Phase
8. Global Peptide Therapeutics Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for Global Peptide Therapeutics Market
9.2. Market Vendor Ranking Analysis for Global Peptide Therapeutics Market
9.3. Competitive News Feed Analysis for Global Peptide Therapeutics Market
10. Company Usability Profiles
10.1. GlaxoSmithKline Plc
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Pfizer Inc
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Sanofi
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Takeda Pharmaceutical Co. Ltd
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Teva Pharmaceutical Industries Ltd
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Amgen Inc
10.7. Bachem Holding AG
10.8. Eli Lilly and Co
10.9. F. Hoffmann-La Roche Ltd
10.10. Novartis AG
11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details